按照歐盟委員會(huì)（EC） No 1924/2006第14章的要求，Biosearch Life公司通過(guò)法國(guó)向歐盟食品安全局提交申請(qǐng)，要求評(píng)估發(fā)酵乳桿菌CECT 5716與降低母乳中葡萄球菌的健康聲稱。

 

    母乳中葡萄球菌可引起乳腺炎。歐盟食品安全局審查了與此相關(guān)的3篇文獻(xiàn)后，得出結(jié)論認(rèn)為，發(fā)酵乳桿菌CECT 5716與降低母乳中葡萄球菌進(jìn)而減少乳腺炎感染風(fēng)險(xiǎn)之間不存在因果關(guān)系。

 

    部分原文報(bào)道如下：

 

    Following an application from Biosearch Life, submitted for authorisation of a health claim pursuant to Article 14 of Regulation （EC） No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies （NDA） was asked to deliver an opinion on the scientific substantiation of a health claim related to Lactobacillus fermentum CECT 5716 and decreases the Staphylococcus load in breast milk. High Staphylococcus load in breast milk is a risk factor for infectious mastitis.